| |
| |
|
| Insider
Information: |
Kakkis Emil D |
| Relationship: |
|
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
603,534 |
|
|
Indirect Shares
|
2,268,639 |
|
|
| Direct
Value |
$26,857,607 |
|
|
|
Indirect Value
|
$94,141,463 |
|
|
| Total
Shares |
2,872,173 |
|
|
| Total
Value |
$120,999,070 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
Chief Medical Officer |
2009-03-02 |
39,621 |
2009-03-02 |
4,654 |
Premium* |
|
|
Ultragenyx Pharmaceutical Inc |
RARE |
|
2024-03-01 |
563,913 |
2024-03-01 |
2,263,985 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
106 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical officer |
• – – |
2009-01-02 |
4 |
AS |
$17.57 |
$298,690 |
D/D |
(17,000) |
39,621 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-11-03 |
4 |
OE |
$18.11 |
$307,938 |
D/D |
17,000 |
114,621 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2009-02-03 |
4 |
AS |
$19.14 |
$325,373 |
D/D |
(17,000) |
39,621 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-10-01 |
4 |
AS |
$26.27 |
$472,878 |
D/D |
(18,000) |
115,304 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-07-07 |
4 |
AS |
$27.90 |
$505,076 |
D/D |
(18,000) |
145,304 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-09-02 |
4 |
AS |
$30.19 |
$543,384 |
D/D |
(18,000) |
115,304 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-08-01 |
4 |
AS |
$32.34 |
$584,578 |
D/D |
(18,000) |
127,304 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2023-10-19 |
4 |
AS |
$33.52 |
$1,604,033 |
D/D |
(47,853) |
599,743 |
0 |
% |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-04-01 |
4 |
AS |
$35.65 |
$291,120 |
D/D |
(8,143) |
96,021 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-04-01 |
4 |
AS |
$35.71 |
$353,835 |
D/D |
(9,857) |
86,164 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-05-01 |
4 |
AS |
$37.31 |
$674,857 |
D/D |
(18,000) |
162,804 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-06-02 |
4 |
AS |
$37.57 |
$677,367 |
D/D |
(18,000) |
160,804 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-03-06 |
4 |
AS |
$37.99 |
$686,870 |
D/D |
(18,000) |
86,164 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2019-09-11 |
4 |
B |
$43.63 |
$218,150 |
D/D |
5,000 |
472,479 |
2.81 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2024-02-07 |
4 |
AS |
$45.00 |
$1,350,000 |
D/D |
(30,000) |
539,770 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2022-12-30 |
4 |
AS |
$45.57 |
$892,352 |
D/D |
(19,582) |
541,108 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2023-03-01 |
4 |
D |
$45.65 |
$736,791 |
D/D |
(16,140) |
599,176 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2023-12-29 |
4 |
AS |
$47.87 |
$1,436,100 |
D/D |
(30,000) |
569,770 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2018-03-01 |
4 |
D |
$48.43 |
$53,951 |
D/D |
(1,114) |
448,955 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2016-07-15 |
4 |
AS |
$50.61 |
$1,016,909 |
D/D |
(20,000) |
507,147 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2017-08-28 |
4 |
B |
$52.40 |
$393,922 |
I/I |
7,500 |
2,559,741 |
2.66 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2024-03-01 |
4 |
D |
$53.69 |
$935,119 |
D/D |
(17,417) |
560,781 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2019-06-01 |
4 |
D |
$54.93 |
$72,892 |
D/D |
(1,327) |
467,479 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2020-03-01 |
4 |
D |
$56.08 |
$386,728 |
D/D |
(6,896) |
504,800 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2017-06-01 |
4 |
D |
$56.61 |
$56,950 |
D/D |
(1,006) |
430,569 |
0 |
- |
|
106 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
